Eosinophils express a functional receptor for interferon α: Inhibitory role of interferon α on the release of mediators

Blood

Volumn 87, Issue 6, 1996, Pages 2354-2360

  Aldebert, Delphine ^b   Lamkhioued, Bouchaïb ^b   Desaint, Corinne ^b   Gounni, Abdelilah Soussi ^b   Goldman, Michel ^b   Capron, André ^b   Prin, Lionel ^b   Capron, Monique ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERFERON RECEPTOR;

ARTICLE; CYTOCHEMISTRY; CYTOTOXICITY; HUMAN; HYPEREOSINOPHILIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029871617     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.6.2354.bloodjournal8762354     Document Type: Article

References (28)

1. Romeo G, Fiorucci G, Rossi G: Interferons in cell growth and development. Tig January 5:1, 1989
2. Müller U, Steinhoff U, Reis L, Hemmi S, Pavlovic J, Zinkernagel R Aguet M: Functional role of type I and type II interferons in antiviral defense. Science 264:1918, 1994
3. Uzé G, Lutfalla G, Gresser I: Genetic transfer of a functional human interferon α receptor into mouse cells: Cloning and expression of its cDNA. Cell 60:225, 1990
4. Platanias L, Pfeffer L, Cruciani R, Colamonici O: Characterization of the IFNα receptor. J Immunol 150:3382, 1993
5. Genot E, Sarfati M, Signaux F, Petit-Koskas E, Billard C, Mathiot C, Falcoff E, Delespesse G, Kolb JP: Effect of interferon-α on the expression and release of the CD23 molecule in hairy cell leukemia. Blood 74:2455, 1989
6. Misiani R, Bellavila P, Fenili D, Vicari O, Marchesi D, Sironi P, Zilio P, Vernocchi A, Massazza M, Vendramin G, Tanzi E, Zanetti A: Interferon alfa 2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751, 1994
7. Coutant G, Bletry O, Prin L, Hauteville D, De Puyfontaine O, Abgrall JF, Godeau P: Traitement des syndromes hypereosinophiliques à expression myéloproliférative par l'association hydroxyuréeinterféron alpha. Ann Med Interne 144:243, 1993
8. Fruehauf S, Fiehn C, Haas R, Doehner H, Hunstein W: Sustained remission of idiopathic hypereosinophilic syndrome following α-interferon therapy. Acta Haematol 89:91, 1993
9. Weller P, Bubley G: The idiopathic hypereosinophilic syndrome. Blood 83:2759, 1994
10. Prin L, Plumas J, Gruart V, Loiseau S, Aldebert D, Ameisen JC, Vermersch A, Fenaux P, Bletry O, Capron M: Elevated serum levels of soluble interleukin-2 receptor: A marker of disease activity in the hypereosinophilic syndrome. Blood 78: 2626, 1991
11. Desreumaux P, Janin A, Dubucquoi S, Copin MC, Torpier G, Capron A, Capron M, Prin L: Synthesis of interleukin-5 by activated cosinophils in patients with eosinophilic heart diseases. Blood 82:1553, 1993
12. Aldebert D, Prin L, Dessaint JP, De Groote D, Capron A, Capron M: Elevation of soluble CD23 in serum from patients with blood eosinophilia. Int Arch Allergy Immunol 103:245, 1994
13. Ruscetti FW, Cypess RH, Chervenick PA: Specific release of neutrophilic and eosinophilic stimulating factors from sensitized lymphocytes. Blood 47:757, 1976
14. Prin L, Capron M, Tonnel A, Bletry O, Capron A: Heterogeneity of human peripheral blood eosinophils: Variability in cell density and cytotoxic in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Immunol 72:336, 1983
15. Hansel T, Pound J, Pilling D, Kitas G, Salmon M, Gentle T, Lee S, Thompson R: Purification of human blood eosinophils by negative selection using immunomagnetic beads. J Immunol 122:97, 1989
16. Churgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294, 1979
17. Capron M, Spiegelberg H, Prin L, Bennich H, Butterworth A, Pierce R, Ouaissi M, Capron A: Role of IgE receptors in effector function of human eosinophils J Immunol 132.462, 1984
18. Langer JA, Pestka S: Interferon receptors. Immunol Today 9:393, 1988
19. Novick D, Cohen B, Rubinstein M: Soluble interferon α receptor molecules are present in body fluids. FEBS Lett 314:445, 1992
20. Abu Ghazaleh R, Fujisawa J, Mestecky J, Kyle A, Gleich GJ: IgA-induced eosinophil degranulation. J Immunol 142 2393, 1989
21. Tomassini M, Tsicopoulos A, Tai P, Gruart V, Tonnel AB, Prin L, Capron A, Capron M: Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin dependent activation. J Allergy Clin Immunol 88:365, 1991
22. Colamonici O, D'Alessandro F, Diaz M, Gregory S, Neckers L, Nordan R: Characterization of three monoclonal antibodies that recognize the interferon α2 receptor. Proc Natl Acad Sci USA 87:7230, 1990
23. Capron M, Plumas J: Eosinophil membrane receptors, in Makino S, Fukuda T (eds): Eosinophils: Biological and Clinical Aspects. Boca Raton, FL, CRC, 1993, p 95
24. Dubucquoi S, Desreumaux P, Janin A, Klein O, Goldman M, Tavernier J. Capron A, Capron M: Interleukin 5 synthesis, by eosinophils: Association with granules and immunoglobulin-dependent secretion. J Exp Med 179:703, 1994
25. Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harada N, Tominaga A, Takatsu K: Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 167:43, 1988
26. Yamaguchi Y, Haysashi Y, Miura Y, Kasahara T, Kitamura S, Torisu M, Mita S, Tominaga A, Takatsu K, Suda T: Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. J Exp Med 167:1737, 1988
27. Capron M, Grangette C, Torpier G, Capron A: The second receptor for IgE in eosinophil effector function. Chem Immunol 47:128, 1989
28. Langhman M, Sanderson C, Nossal J: Soluble interleukin 2 receptors are released from the all surface of normal murine B lymphocytes stimulated with interleukin 5. Proc Natl Acad Sci USA 85:3115, 1988